ClinicalTrials.Veeva

Menu

Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis (METHO-PR)

C

Centre Hospitalier Universitaire, Amiens

Status

Unknown

Conditions

Methotrexate
Polyarthritis; Rheumatoid

Treatments

Other: Communication methods to encourage adherence

Study type

Interventional

Funder types

Other

Identifiers

NCT03107299
PI2016_843_0006

Details and patient eligibility

About

Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). Poor adherence of this treatment decreases the control of the disease and the effectiveness of the associated treatments.

The aim would be to study the observance of patients with RA and to be able to propose adequate solutions favoring patient compliance and thus the stability of the pathology.

For this purpose, 3 methods of communication have been put in place to encourage adherence: usual care by the rheumatologist, sms sending or pharmaceutical maintenance.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients attending Day Hospital or consultation of rheumatology with rheumatoid polyarteritis and under treatment with MTX alone or in combination with another therapeutic, fixed dosage for at least 3 months.
  • Consenting Patient
  • Literate French-speaking patient,
  • Patient with a mobile phone
  • Patient affiliated to a social security scheme

Exclusion criteria

  • Patient not managing his own treatment

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 3 patient groups

Control
Other group
Treatment:
Other: Communication methods to encourage adherence
Send sms to patients
Other group
Treatment:
Other: Communication methods to encourage adherence
pharmaceutical maintenance following medical consultation
Other group
Treatment:
Other: Communication methods to encourage adherence

Trial contacts and locations

1

Loading...

Central trial contact

Vincent GOEB, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems